Follow the 젠큐릭스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 젠큐릭스 has published 2 public disclosures. Market capitalisation: €35.7bn. The latest transaction was reported on 14 July 2026 (Other). Among the most active insiders: 조상래. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
젠큐릭스 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para el diagnóstico médico.